A 43-year-old woman with bipolar disorder and advanced HIV infection was admitted to this hospital because of depressed mood, ...

“Research indicates that seasonal affective low mood may be informed by some people’s response to a decrease in daylight ...

If standard treatments haven’t worked, don’t lose hope. Discover what treatment-resistant bipolar disorder means and new ...

The approval is supported by a combination of current clinical data and model-informed drug development techniques.

Abstract: Major depressive disorder (MDD) is a global mental health problem that significantly affects individuals’ daily activities. The diagnosis of MDD is a challenging issue due to people’s stigma ...

This is a developing news story. Please check back soon for updates. The FDA approved extended-release Uzedy for the ...

Teva Pharmaceuticals' Uzedy therapy to treat bipolar I disorder received approval from the Food and Drug Administration. The biopharmaceutical company said Friday the therapy was approved as a ...

FDA approves UZEDY ® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to ...

Schizoaffective bipolar disorder is a rare mental health condition that displays characteristics of bipolar disorder and ...

While borderline personality disorder and bipolar disorder share common symptoms like reckless behavior, there are a few key ...

Bipolar disorder is a mental health condition characterized by extreme mood swings, including periods of mania (elevated mood ...